Dr Reddy's Gets SEC Nod for Higher Semaglutide Dose in Ongoing Phase III Study, Govt Sites Mandated Dr. Divya Colin30 May 2025 8:14 PM ISTNew Delhi: In response to the proposal presented by the Dr Reddy's Laboratories, the Subject Expert Committee (SEC) functional under the Central Drug...
USFDA Inspection: Dr Reddy's gets Form 483 with 7 observations for Bollaram facility Farhat Nasim20 Nov 2024 1:48 PM ISTNew Delhi: Dr Reddy's Laboratories Ltd on Tuesday said the US health regulator has issued a Form 483 with seven observations to its active...
Granules India appoints Ramraj Rangarajulu as President, Head of Formulations Operations MD Bureau17 Oct 2024 6:17 PM ISTNew Delhi: Granules India Limited has recently announced the appointment of Ramraj Rangarajulu as President and Head of Formulations Operations,...
Indian branded pharma Sector sees a decline in growth: Report Farhat Nasim9 Oct 2024 6:54 PM ISTCompanies such as Dr Reddys Laboratories (DRRD), Zydus Lifesciences (ZYDUSLIF), Lupin (LPC), and Mankind Pharma (MANKIND) expected to outperform on a...
Cipla Buyout Battle: Dr Reddys, Bain Capital to team up for joint bid? Drugmaker issues statement Farhat Nasim6 Sept 2023 3:36 PM ISTNew Delhi: The buyout battle for 33.47 percent promoter stake in Cipla, owned by the Hamied family has intensified as US-based private equity...
Dr. Reddy gets CDSCO Panel Nod for comparative bioavailability study of Rabeprazole Modified Release capsule Dr. Divya Colin5 Jun 2023 6:00 PM ISTNew Delhi: Granting approval to Dr. Reddy's Laboratories for conducting the comparative bioavailability study of the proton pump inhibitor Rabeprazole...
Need well-designed protocol with statistically validated sample size: CDSCO Panel Tells Dr. Reddy's on Nerivio Dr. Divya Colin4 Jun 2023 6:00 PM ISTNew Delhi: In line with the proposal to conduct a pivotal clinical investigation of the proposed product Nerivio, the Subject Expert Committee (SEC)...
Dr Reddy's gets CDSCO panel nod to manufacture, market lipid-regulating agent Icosapent ethyl capsules Dr. Divya Colin6 Feb 2023 6:00 PM ISTNew Delhi: Drug major, Dr Reddy's Laboratories has got a go ahead from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
Dr. Reddy proposal to market antidiabetic FDC of Imeglimin and Vildagliptin rejected by CDSCO Panel Dr. Divya Colin2 Nov 2022 6:00 PM ISTNew Delhi: Noting that the clinical experience with the drug Imeglimin is very limited, the Subject Expert Committee (SEC) functional under the...
Dr Reddy's, Cipla, Aurobindo units recall products in US market Kajal Rajput25 Oct 2022 5:13 PM ISTNew Delhi: Leading drug firms Dr Reddy's Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various...
Medley Pharma up for sale, expected to be sold for Rs 5,000 crore Susmita Roy26 May 2022 11:06 AM ISTNew Delhi: Medley Pharma, a privately held Mumbai-based pharmaceutical company, is up for sale and is expected to be sold for Rs 5,000 crore in a...
Pharma company Dr. Reddy's plans business continuity in Russia MD Bureau10 March 2022 5:09 PM ISTThe company said in its annual report last year that its focus was on "scaling up in our major markets, which include Russia, China, Brazil, South...
